- Filed
- Nov 4, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Oct 31, 2021 | 50.27M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 50.56M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 46.74M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 43.62M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 43.11M sh |
| Capex | Q3 2021 · Sep 30, 2021 | $63.12M |
| Capex | Q3 2021 · Sep 30, 2020 | $46.95M |
| Operating Cash Flow | Q3 2021 · Sep 30, 2021 | −$43.41M |
| Operating Cash Flow | Q3 2021 · Sep 30, 2020 | $554.38M |
| Long Term Debt | Q3 2021 · Sep 30, 2021 | $536.24M |
| Long Term Debt | Q3 2021 · Dec 31, 2020 | $15.16M |
| Short Term Debt | Q3 2021 · Sep 30, 2021 | $3K |
| Short Term Debt | Q3 2021 · Dec 31, 2020 | $50.09M |
| Cash And Equivalents | Q3 2021 · Sep 30, 2021 | $585.58M |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $84.44M |
| Cash And Equivalents | Q3 2021 · Sep 30, 2020 | $97.19M |
| Stockholders Equity | Q3 2021 · Sep 30, 2021 | $1.68B |
| Stockholders Equity | Q3 2021 · Dec 31, 2020 | $1.17B |
| Current Liabilities | Q3 2021 · Sep 30, 2021 | $200.77M |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $245.97M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $768.94M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $287.44M |
| Current Assets | Q3 2021 · Sep 30, 2021 | $1.56B |
| Current Assets | Q3 2021 · Dec 31, 2020 | $658.23M |
| Total Assets | Q3 2021 · Sep 30, 2021 | $2.44B |
| Total Assets | Q3 2021 · Dec 31, 2020 | $1.46B |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | $0.83 |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | $3.41 |
| Eps Diluted restated | Q3 2021 · Sep 30, 2020 | $0.51 |
| Eps Diluted restated | Q3 2021 · Sep 30, 2020 | $2.17 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | $0.84 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | $3.44 |
| Eps Basic restated | Q3 2021 · Sep 30, 2020 | $0.57 |
| Eps Basic restated | Q3 2021 · Sep 30, 2020 | $2.39 |
| Sga Expense | Q3 2021 · Sep 30, 2021 | $34.35M |
| Sga Expense | Q3 2021 · Sep 30, 2021 | $100.55M |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $31.06M |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $86.97M |
| Operating Income | Q3 2021 · Sep 30, 2021 | $51.06M |
| Operating Income | Q3 2021 · Sep 30, 2021 | $180.48M |
| Operating Income restated | Q3 2021 · Sep 30, 2020 | $23.64M |
| Operating Income restated | Q3 2021 · Sep 30, 2020 | $96.03M |
| Gross Profit | Q3 2021 · Sep 30, 2021 | $88.91M |
| Gross Profit | Q3 2021 · Sep 30, 2021 | $286.22M |
| Gross Profit restated | Q3 2021 · Sep 30, 2020 | $73.96M |
| Gross Profit restated | Q3 2021 · Sep 30, 2020 | $202.07M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2021 | $917.43M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2021 | $2.08B |
| Cost Of Revenue | Q3 2021 · Sep 30, 2020 | $498.4M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2020 | $1.39B |
| Revenue | Q3 2021 · Sep 30, 2021 | $919.06M |
| Revenue | Q3 2021 · Sep 30, 2021 | $2.14B |
| Revenue | Q3 2021 · Sep 30, 2020 | $492.87M |
| Revenue | Q3 2021 · Sep 30, 2020 | $1.35B |